Introduction
Preterm birth is an international major public health concern, with rates high and rising in many parts of the world. In 2006, 12.8% of all births in the US were preterm, defined as delivery before 37 completed weeks of gestation [1] . Preterm birth is the second leading cause of infant mortality and the leading cause of mortality among black infants in the US as well as the major contributor to worldwide infant mortality and morbidity [2] . Children born preterm may suffer lifelong morbidities including lung disease, vision and hearing deficits and other neurosensory impairments [3] as well as predisposition to hypertension and diabetes in adult life [4] . While many environmental contributors to preterm birth have been proposed (e.g. infection, stress and smoking), most preterm births remain unexplained. Several pathways leading to preterm birth have been outlined, including (1) inflammation, (2) maternal/fetal stress, (3) uterine distension and cervical dysfunction, (4) decidual hemorrhage, and (5) metabolic enzyme variation [5, 6] . A modest body of literature has examined the complex genetic contribution to preterm birth [7] [8] [9] , with heritability estimates in the range of 27-36% [10, 11] . Several studies have reported associations with single gene variants [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . These studies have been hampered by varying definitions of preterm birth, as well as small sample sizes and failure of replication, possibly reflecting publication bias. It remains a challenge to identify robust associations between genetic variation and preterm birth risk.
Material and Methods
In conjunction with the Human Genome Epidemiology Network (HuGENet), the World Health Organization, Albert Einstein College of Medicine, Massachusetts General Hospital, and March of Dimes, members of the Preterm Birth International Collaborative (PREBIC) have created PTBGene, a regularly updated online, publicly available database of all genetic association studies published in the field of preterm birth to date. This is modeled after an approach to creating field synopses for Alzheimer's disease and schizophrenia developed at Massachusetts General Hospital [22, 23] and following the recommendations for reporting proposed by the meta-analysis of observational studies in epidemiology group [24] . PTBGene is implemented using Oracle database technology. Data are captured in a relational database and the web application was developed using the PL/SQL web toolkit. PTBGene is accessible at http://ric.einstein.yu.edu/ ptbgene/index.html.
Literature Searches
This research was reviewed by the Institutional Review Board at Montefiore Medical Center and was found to be exempt. MED-LINE and EMBASE were searched using a comprehensive search strategy ( table 1 ) to identify all studies reporting on genetic associations with preterm birth in humans published between January 1, 1990 and December 1, 2008, with no language restrictions. The search strategy was designed to be broad and inclusive since preterm birth can be referred to in many ways, including preterm birth, preterm delivery, preterm labor, premature birth, etc. The phenotype of interest was defined as singleton preterm birth. The search identified 6,772 abstracts. Eight authors are PREBIC members (S.M.D., M.V.H., M.M., A.P.B., J.N., B.K.L., D.R.V., R.M.). Based on their expertise in preterm birth, they screened the abstracts, reviewed the articles and extracted the data in pairs. The abstracts were screened independently by 2 authors according to the following inclusion and exclusion criteria to identify the studies, providing the pertinent information regarding singleton preterm birth in humans. They had to provide the case definition of preterm birth in gestational weeks at delivery and genotypes for the cases and controls (maternal, newborn and/or paternal). Studies exclusively of twins were excluded, as were case only studies, case reports, family-based studies, and review articles.
The screening yielded 139 abstracts for which the full-text articles were obtained and archived electronically and in paper version. Two different authors then reviewed the articles, compared their independent selections and came to a consensus on the 61 articles that met the inclusion and exclusion criteria. These 61 articles had data extracted ( table 2 ) .
To assess our ability to identify the appropriate articles, we compared our results to those of HuGE Navigator [25] , an integrated, searchable knowledge base of genetic associations and human genome epidemiology [26] , and the Genetic Association Database (GAD) [27] which were searched for preterm birth. HuGE Navigator identified 67 articles and GAD identified 68, but these included review articles and articles examining pediatric outcomes after preterm birth such as retinopathy of prematurity, which we excluded. We checked to confirm that we had considered all articles found by HuGE Navigator and GAD.
Data Extraction
The data extraction was performed by one author (PREBIC member) and checked by a second. A set of data for each variant was extracted from the articles and entered into a spreadsheet, including the gene name and variant as identified by the official symbol and GeneID in NCBI's Entrez Gene [28] , and the rs number from dbSNP [29] . The first author's last name, year and journal of publication and PubMed ID were extracted. The geographic location of the population studied was recorded as city and country. One field identified whether the variant was reported in maternal DNA, newborn DNA or paternal DNA. The definition of preterm in gestational weeks was recorded as was the case definition of preterm, categorized as (1) spontaneous preterm birth (defined as preterm birth following spontaneous preterm labor), (2) preterm birth following preterm premature rupture of the membranes (PPROM), (3) preterm birth following maternal medical complications such as preeclampsia and diabetes, (4) preterm birth following fetal complications such as small for gestational age or intrauterine growth restriction, or (5) preterm birth not otherwise specified. In some cases, 2 codes were assigned for case definition if, for example, the cases reported included spontaneous preterm births as well as those following PPROM. Also, the reported ancestry of the mothers in the study was coded according to a scheme used previously [22, 30] . The 5 general groups of origin were (1) African, (2) Asian, (3) Caucasian (of European descent), (4) Hispanic, and (5) mixed/other. For each polymorphism (usually rs ID) and ethnic group, the number of cases and controls was recorded as well as the major and minor allele for the single nucleotide polymorphism (SNP). In cases where there was inconsistency in reporting major versus minor allele between studies, we delineated the ancestral allele at dbSNP [29] as the major allele. Additionally, the number of cases and controls with each genotype (minor/minor, minor/major, major/major) was recorded. In cases where genotypes were not provided in the articles, the corresponding authors were contacted and asked to for the genotype data which were then included when provided. Only corresponding authors who were also PREBIC members responded to our queries, but as more researchers learn of PTBGene, we expect that more extensive data can be captured. This constituted the data set for the meta-analyses.
Statistical Analysis
Whenever there were 3 or more different datasets evaluating the same genetic variant in mothers, fathers or newborns, a metaanalysis was performed. The primary analyses combined data on all relevant studies and a secondary analysis performed separate analyses according to racial descent.
We used the odds ratio (OR) as the metric of choice for all meta-analyses. In the absence of strong biological rationale for any specific genetic model for any of the probed associations, the main analyses were performed using allele-based comparisons. Calculations were performed with Statistical Analysis Software (SAS), version 9.1.3. All p values are two-sided.
Statistical heterogeneity among the studies was evaluated by Cochran's Q [31] , considered significant at p ! 0.10. Both fixedeffects and random-effects models were used for summary effects. However, since the Q test is insensitive to small/few studies, we based our main inferences on the random-effects model. This model assumes that the studies are a random sample of a hypothetical population of studies taking into account within-and between-study variability. We also used the I 2 metric [31, 32] as a measure of the extent of between-study heterogeneity; values of 50% or higher are considered to express large between-study het- Step 1 'immaturity' or 'premature labor' or prematurity or 'premature birth*' or prematurity or 'low birth weight' or 'low-birth-weight infant' or 'very low birth weight' or 'very-low-birth-weight infant' or 'premature labour' or 'premature labor' or 'preterm birth' or 'pre-term infant*' or 'preterm infant*' or 'pre-term bab*' or 'preterm bab*' or 'pre-term deliver*' or 'preterm deliver*' or 'premature deliver*' or 'pre-mature deliver*' or 'pre-term birth*' or 'preterm birth*' or 'premature bab*' or 'pre-mature bab*' or 'premature infant*' or 'pre-mature infant*' or 'premature infant' or 'premature infant*' or 'low birth weight' or 'very low birth weight' or 'small for date infant' or 'small for gestational age'
Step 2 'pregnancy complication*' OR 'pregnancy complication' OR 'pregnancy' or 'pregnan*' or 'gestational age'
Step 3 'premat*' or 'pre-matur*' or 'early labour*' or 'early labor*' or 'preterm*' or 'pre-term*' (Step 2 AND Step 3) or Step 1
Step 4 'population genetic parameters' or 'environmental carrying capacity' or 'familial incidence' or 'gene frequency' or 'genetic distance' or 'genetic drift' or 'genetic stability' or 'genetic variability' or 'microsatellite instability' or 'neutral gene theory' or 'combining ability' or 'genetic linkage' or 'heredity' or 'allelism' or 'cancer genetics' or 'genealogy' or 'evolutionary adaptation' or 'genetic compatibility' or 'genetic cross' or 'genetic damage' or 'genetic heterogeneity' or 'genetic line' or 'genetic resource' or 'genome' or 'genotype' or 'human genetics' or 'hybridization' or 'immunogenetics' or 'inheritance' or 'autosomal inheritance' or 'dominant inheritance' or 'multifactorial inheritance' or 'genetic predisposition' or 'recessive inheritance' or 'sex chromosomal inheritance' or 'zygosity' or 'mathematical genetics' or 'mutation' or 'pharmacogenetics' or 'phenotype' or 'population genetics' or 'quantitative genetics' or 'genetic and familial disorders' or 'familial disease' or 'genetic disorder' or 'chromosome aberration' or 'hereditary connective tissue disease' or 'hereditary optic atrophy' or 'inborn error of metabolism' or 'monogenic disorder' or 'multifactorial genetic disorder' or 'genetic*'
Step 5
Step 4 AND ([Step 2 AND
Step 3] or Step 1) 6 ,772 citations identified. 6 ,772 abstracts were identified and screened. 139 full-text articles were retrieved. 61 articles had data extracted.
erogeneity and values of 25-50% express moderate between-study heterogeneity. With a small number of studies, I
2 can have large uncertainty, so inferences should be interpreted cautiously [32] .
We performed sensitivity analyses exploring the possibility for bias. For the formally statistically significant associations (those with p ! 0.05 on random-effects calculations) where an adequate number of studies existed, we evaluated whether the results were different after exclusion of the first-published study and after exclusion of studies that had significant (p ! 0.05) violation of Hardy-Weinberg equilibrium (HWE) in the controls, according to an exact test [33] . We did not apply regression diagnostics for asymmetry that may reflect publication bias, other biases, quality differences, or genuine heterogeneity between small and larger studies, since all meta-analyses had a limited number of studies [34, 35] . For the same reason, we did not apply tests for excess of single studies with significant findings [36] .
Assessment of Cumulative Evidence
We applied a grading system to each nominally significant association that assesses the epidemiological strength of the cumulative evidence through a process in which the first author (S.M.D.) assigned the grades which were then checked by the epidemiologist who presented the criteria in detail elsewhere (J.P.I.) [37] . There were no disagreements. Briefly, each meta-analyzed association is graded based on the amount of evidence, replication and protection from bias in an objective fashion according to the following guidelines. For amount of evidence, grade A is assigned when the total number of minor alleles of cases and controls combined is 1 1,000, B when it is 100-1,000 and C when it is ! 100. For replication consistency, C reflects point estimates of I 2 1 50%, B is 25-50% and A is ! 25%. For protection from bias, grade A means that bias, if present, may change the magnitude but not the presence of an association; grade B means that there is no evidence of bias that would invalidate an association, but important information is missing; and grade C means that there is demonstrable potential or clear bias that may invalidate the mere presence of an association. We consider various potential sources of bias by carefully reviewing methods, including errors in phenotypes, genotypes, confounding (population stratification), and errors/biases at the meta-analysis level (publication and other selection biases). When the summary OR deviates less than 1.15-fold from the null, for meta-analyses based on published data, we acknowledge that occult publication and selective reporting biases alone may invalidate the association, regardless of the presence or not of other biases, therefore the grade is C. When the summary OR deviates more than 1.15-fold from the null, grade C is given when nominal statistical significance is lost with the exclusion of the first-published study or with correction for HWE-violating studies. For large OR estimates, we consider that phenotype misclassification may affect the magnitude but not the presence of an effect in this field; genotyping errors are also considered to affect the magnitude but usually not the presence of significant associations of such magnitude. Potential confounding from population stratification is also considered to have a similar impact (given that at least self-reported racial descent is taken into account in all our analyses).
Associations that get 3 A grades are considered to have 'strong' epidemiological credibility. Associations that get any B, but not any C grade, are assigned 'moderate' credibility, and associations that get any C grade are considered to have 'weak' credibility.
Results
Sixty-one eligible articles provided data on 189 polymorphisms in 84 genes. These included 46 articles reporting data on maternal DNA (127 polymorphisms in 48 genes), 31 articles reporting newborn DNA (145 polymorphisms in 68 genes) and 2 articles reporting paternal DNA (4 polymorphisms in 3 genes).
Of the 46 articles that reported on maternal genotypes, 32 defined preterm birth as birth before 37 completed weeks of gestation, 6 articles used a definition of 36 weeks, 4 used 35 weeks, 2 used 34 weeks, and 2 used 32 weeks. Of the 31 articles reporting on newborn genotypes, 15 used a 37 week cut-off, 6 used 36 weeks, 7 used 35 weeks, one 34 weeks, one 30 weeks, and one 27 weeks. The 2 articles that reported paternal genotypes used 37 weeks as the case definition.
In the maternal reports, 23 articles defined a case as spontaneous preterm birth, 1 defined it as following PPROM, 8 defined it as spontaneous preterm birth or preterm birth following PPROM, and 14 did not define the case beyond preterm. In the newborn reports, 10 articles defined a case as spontaneous preterm birth, 1 defined it as following PPROM, 3 combined spontaneous and PPROM cases, 1 combined maternal and fetal indications as well as spontaneous preterm birth in the case definition, and 16 did not define the case beyond preterm. Neither of the 2 paternal reports had a detailed case definition.
Overall only 19 of the 46 maternal and 14 of the 31 newborn studies had more than 100 cases. Sufficient data to perform meta-analysis were available for 22 polymorphisms in 15 genes for maternal DNA and 14 polymorphisms in 8 genes for newborn DNA (reflecting 107 and 62 datasets, respectively). No sufficient data were available to examine paternal genetic associations. We did not combine paternal with maternal data for analysis as the paternal contribution to preterm birth is thought to be much smaller than the maternal [38] .
Of the 22 polymorphisms in 15 genes studied in metaanalyses for maternal DNA variants, 4 variants, including an 86 bp VNTR in interleukin 1 receptor antagonist ( IL1RN ) and 3 SNPs in beta-2 adrenergic receptor ( ADRB2, rs1042713), interferon gamma ( IFNG, rs2430561), and factor 2 ( F2 , rs1799963) showed nominally significant summary ORs with modest p values in the main (allele-based) analyses (ORs ranging from ϳ 1.4 to ϳ 1.8, p values ranging from 0.01 to 0.04, table 3 ). Of the 14 polymorphisms in 8 genes studied in meta-analyses of newborn DNA variants, the same SNP in coagula-tion factor 2, also showing association in the maternal analyses ( F2, rs1799963), yielded a nominally significant OR of 1.81 (p = 0.03) ( table 3 ). The 5 respective forest plots are shown in figure 1 .
Functional Considerations for Identified Nominally Significant Associations
Little is known about the precise mechanisms by which the identified genes contribute to preterm birth. Brief functional considerations are provided, but further research is warranted to learn about mechanisms of action.
The IL1RN gene (GeneID 3557) [28] encodes a protein that inhibits the activities of IL1A (interleukin 1 alpha) and ( IL1B ) and interleukin 1 beta. The IL1 cytokine family is involved in immune and inflammatory responses and the 86 base pair VNTR in IL1RN may therefore play a role in preterm birth through its effect on inflammatory response.
ADRB2 is the gene that encodes beta-2-adrenergic receptor, a member of the G protein-coupled receptor superfamily (GeneID 154) [28] . The nominally associated coding exon SNP rs1042713 results in the amino acid change Arg16Gly which is hypothesized to enhance the rate of ␤ -agonist-induced desensitization and thus to protect against preterm birth [39, 40] .
IFNG encodes interferon gamma, GeneID 3458 [28] . IFNG is involved in transcriptional regulation of a variety of genes involved in the immune response and coordinates a diverse array of cellular programs [41] . The nominally associated rs2430561 correlates with lower levels of interferon gamma production which may mitigate the immunotolerance required for pregnancy maintenance and increase risk for preterm birth [20, 42] .
The last nominal association is with rs1799963 in F2 , coagulation factor II (GeneID 2147) [28] . Coagulation factor II is involved in the first step of the coagulation cascade in which it is proteolytically cleaved to form thrombin. F2 variants can be associated with thrombosis, and the fact that F2 was identified in both maternal and newborn samples suggests that thrombosis may play a key role in the etiology of preterm birth.
Grading the Evidence
None of the 5 nominal associations had formal statistical significance when analyses were limited to studies of Caucasian descent populations, but effect sizes did not change markedly. Using interim guidelines to assess the 'epidemiological credibility' of these associations [37] , we found that for 'amount of evidence', 3 nominal associations in maternal DNA were graded B, while the associations for rs1799963 in the maternal and newborn analyses were graded C. I 2 was less than 25% in 3 of the 5 associations (grade A) and 36% and 28% in the other 2 (grade B). The magnitude of the effect deviated more than 1.15-fold from the null for all 5 associations, but 3 lost their nominal significance and the other 2 had less than 3 studies left when the first study was excluded. Moreover, the phenotype definitions left room for considerable bias. Therefore, all 5 associations were graded C for protection from bias. As a result, all 5 nominal associations were graded as having only 'weak' epidemiological credibility (overall grade C) per interim guidelines ( table 4 ). Landau (2002) [53] *Ozkur (2002) [40] A-allele vs. G-allele 
Summary ORs
All studies All excl initial study All excl HWE deviations All Caucasian studies 
Amount of evidence: Grade is A when the total number of minor alleles of cases and controls combined is >1,000, B when it is 100-1,000 and C when it is <100. Replication consistency: C reflects point estimates of I 2 >50%, B is 25-50%, and A is <25%. Protection from bias: Grade A means that bias, if present, may change the magnitude but not the presence of an association; grade B means that there is no evidence of bias that would invalidate an association, but important information is missing; grade C means that there is demonstrable potential or clear bias that may invalidate the mere presence of an association.
Discussion
This field synopsis of genetic associations with preterm birth reveals a paucity of research in the field, compared with more mature genetic association fields like schizophrenia [23] and Alzheimer's disease [22] . So far, no robustly replicated genetic variants contributing to this complex disease have been identified. All 5 identified nominally significant associations were graded as having weak credibility [37] . For the field to progress, the obstacles of small studies, publication and reporting biases and lack of common standards worldwide [43] need to be overcome.
Our evaluation revealed considerable problems in phenotype definition. There was large variability in the gestational cut-off used to define preterm birth. Exclusion of preterm births due to maternal or fetal indications was inconsistent. A clear phenotypic case description, according to common standards worldwide, is necessary to improve this area of research [44] . If investigators analyze associations using different cut-off definitions and report only the most impressive results, this will introduce the bias of multifarious outcomes with selective reporting [45] .
This field synopsis also reveals that small studies abound in the field of preterm birth research. Most of these studies, individually and in meta-analysis, lack the power to detect the modest effect sizes observed here or in similar systematic field synopses of complex genetic diseases [22, 23] . Creation of large multicenter collaborations and consortia should be encouraged [46] with the goal of designing adequately powered studies using consistent phenotype definitions and enhancing involvement of low-resource countries. For postulated associations to date, replication efforts have been limited and even combining data in meta-analyses does not yield large enough sample sizes. Also, such small studies have limited ability to address population admixture issues as they do not have adequate power to perform ancestryspecific analyses [47] [48] [49] .
Lastly, this field synopsis points out the challenges of studying an outcome such as preterm birth which is influenced by multiple genomes: the maternal, fetal and paternal genomes [38, 50] . Several triad studies are underway that may reveal genetic interactions between maternal, paternal and fetal genetic variants influencing preterm birth. However, additional methods for dealing with the task of identifying genetic associations with preterm birth, accounting for the multiple genomes, as well as environmental factors need to be developed.
We plan to keep updating this field synopsis online at PTBGene, the Preterm Birth Genetics Knowledge Base, and to re-evaluate the data on the cumulative evidence on genetic associations with preterm birth [51] . Genomewide association studies (GWAS) are allowing high throughput hypothesis-free exploration of genetic contribution to a variety of complex outcomes. Several preterm birth GWAS expect to have results in 2010. Preterm birth research will likely benefit greatly from GWAS findings and PTBGene will incorporate data from such studies as they become available following the approach developed for AlzGene and SzGene for inclusion of largescale genetics studies and merging them with candidategene data [22, 23] . Hopefully, better clinical and phenotypic characterization of study subjects, as well as larger-scale multi-center collaborations using common standards and high throughput platforms, will lead to progress in deciphering the genetic factors underlying preterm birth.
